bioRxiv Science⌕ Search

Biology subjects

Bilgel, M.

Publications and source records attributed to Bilgel, M..

11 recordsLinked to original sources

Automated Segmentation of Brainstem and Subcortical White Matter: Mapping the Deep Tegmental Core with BundleParc

Diffusion MRI enables noninvasive mapping of human white matter pathways, but automated segmentation methods have largely focused on large association, projection, and commissural bundles. Brainstem and subcortical pathways supporting basal ganglia, cerebellar, limbic/reward, sensory, and homeostatic functions remain underrepresented in large-scale connectomic analyses. To address this gap, we adapted BundleParc, a recently introduced bundle-parcellation architecture, into an automated pipeline for direct segmentation and along-tract parcellation of 97 subcortical and brainstem white matter pathways. The model was trained on a curated reference dataset derived from Human Connectome Project diffusion MRI using anatomy-guided tractography, explicit inclusion and exclusion criteria, automated outlier filtering, and manual quality assurance. Operating directly on native-space fiber orientation distributions, the algorithm successfully recovers these intricate anatomical trajectories and ordered parcellations. We show the model generalizes to diverse external datasets spanning development, aging, and neurodegenerative disease cohorts, maintaining robust performance across variations in spatial resolution and angular sampling. The released container, trained model, population atlas, reference streamlines, and quality assurance outputs provide a resource for studying deep brainstem and subcortical pathways in development, aging, disease, and neuromodulation-relevant anatomy.

neuroscience↗

Charting Cervical Spinal Cord Morphometry Across the Lifespan

Spinal cord morphometry provides essential biomarkers of neurological health, but clinical interpretations are confounded by inter-subject variability and a lack of normative references across the full human lifespan. We address this gap by generating the first comprehensive lifespan charts for cervical spinal cord morphometry. We leveraged 30 population-based brain MRI datasets, aggregating 78,269 scans from 41,042 individuals (ages 0-100) whose imaging protocols included cervical cord coverage. To overcome contrast variability, we employed a state-of-the-art contrast-agnostic deep learning segmentation method, extracting cross-sectional area (CSA), anteroposterior (AP) and right-left (RL/transverse), and shape indices (compression ratio, eccentricity, and solidity) from C1 to C7. Normative trajectories were modeled using Generalized Additive Models for Location, Scale, and Shape (GAMLSS). The resulting charts reveal distinct non-linear lifespan changes: rapid growth through childhood and adolescence, peak maturation occurring in early-to-mid adulthood (e.g., mid-30s for CSA), followed by gradual decreases. Significant regional variations along the cervical cord and consistent sex differences (males > females for size metrics) were quantified. Spinal cord trajectories showed strong temporal coupling with brain white matter and brainstem volumes, suggesting integrated CNS development and aging. These lifespan charts provide a robust normative framework, enabling age- and sex-specific centile scoring of individual spinal cord morphometry. This resource offers a critical tool for differentiating typical variation from pathological changes, enhancing the clinical utility of spinal cord MRI in studies of development and neurodegeneration.

neuroscience↗

Building an open ecosystem for molecular neuroimaging: standards and tools from the OpenNeuroPET initiative

Molecular neuroimaging with positron emission tomography (PET) and single-photon emission computed tomography (SPECT) enables quantification of specific molecular targets in the living brain. Despite its scientific impact, molecular neuroimaging research has historically faced challenges due to high costs, small sample sizes, laboratory-specific analysis pipelines, and limited large-scale data sharing. These factors have hindered reproducibility and the broader reuse of valuable PET datasets. The OpenNeuroPET initiative was established to address these barriers by developing standards, infrastructure, and open-source tools currently focused on PET. Through collaborations across Europe and North America, OpenNeuroPET has supported the PET extension of the Brain Imaging Data Structure (PET-BIDS), providing a standardized framework for PET datasets and metadata. Building on PET-BIDS, tools such as PET2BIDS, ezBIDS, and BIDSCoin facilitate data conversion and curation. In parallel, OpenNeuro now hosts PET-BIDS datasets for open sharing, while complementary platforms such as PublicnEUro provide controlled-access pathways designed to support compliance with the European Union General Data Protection Regulation (GDPR). Emerging open-source workflows further support automated, reproducible PET analysis, promoting harmonization across centers. Together, these developments mark an important step toward an open molecular neuroimaging community in which datasets, software, and workflows can be transparently shared, reused, and scaled for collaborative research.

bioinformatics↗

Modeling a Shared Reality of Tractography through Varied Structural Imaging

Though diffusion MRI (dMRI) is the gold standard for white matter tractography, fundamental questions remain about whether captured patterns reflect diffusion-specific phenomena or general structural properties accessible through alternative imaging approaches. This work investigates structural probabilities within the human brain as a complex manifold and examines structural-functional relationships of anatomical bundles to clarify what dMRI specifically captures in white matter architecture. We introduce a framework to extract white matter pathways from FLAIR images without additional subject-specific anatomical context. Using a teacher-student model, we capture systemic information from dMRI-based tractography to guide FLAIR-based tractogram creation. The teacher model trains on dMRI features to generate diffusion tractography, while the student utilizes frozen teacher layers to extract tractography features using only FLAIR input. In our pilot analysis of 14 randomly selected subjects from the Baltimore Longitudinal Study of Aging (BLSA), we performed additional inference on 9 withheld subjects to evaluate robustness. We assessed FLAIR-template generated streamlines using bundle adjacency and Dice coefficient at the voxel level across 39 white matter bundles compared to gold standard diffusion streamlines. Statistical evaluations compared our method against other non-diffusion tractography algorithms using T1-weighted and FLAIR images with subject-specific anatomical context. Results demonstrate our proposed method offers statistically similar performance to other non-diffusion methods when compared to diffusion streamlines These findings suggest that without diffusion data, our method captures unconditional subject-specific prior probabilities of tractography, indicating that tractography patterns may sample from a shared latent space of structural information not unique to any single imaging sequence.

bioengineering↗

Analytic Bounds on GAMLSS Model Variability of Normative White Matter Brain Charts

Brain charts, or normative models of quantitative neuroimaging measures, can identify trajectories of brain development and abnormalities in groups and individuals by leveraging large populations. Recent work has extended these brain charts to model microstructural and macrostructural features of white matter. Assessments of variance for these brain charts are necessary to determine whether the models being used for these data are stable. We implement an analytic approach to characterize variability of the parameters in previously released brain charts created using the generalized additive models for location, scale, and shape (GAMLSS) framework. Additionally, we empirically validate the accuracy of each analytic model through a comparison to a bootstrapping approach from 0.2 to 90 years of age. We find that across all models, the analytic coefficient of variation (COV) remains below 5% for ages greater than 0.25 years, with the maximum empirical observed COV reaching 7% at 0.2 years of age. Further, the empirical assessment shows high agreement with the analytic assessment, with COV estimates averaged across the lifespan for all models having a Pearson correlation coefficient of 0.776 and a mean difference of 4 x 10-4. Both methods exhibit volume and surface area as the features with the largest average COV for the majority of tracts. However, the analytic assessment yields axial diffusivity as the feature most frequently having the smallest COV, whereas the corresponding feature for the empirical assessment is average length. These results suggest that the analytic approach overestimates model stability for WM brain charts when the COV is low and that the validation method is suitable for assessing whether GAMLSS models are unstable.

bioengineering↗

Building Multivariate Molecular Imaging Brain Atlases Using the NeuroMark PET Independent Component Analysis Framework

Molecular imaging analyses using positron emission tomography (PET) data often rely on macro-anatomical regions of interest (ROI), which may not align with chemo-architectural boundaries and obscure functional distinctions. While methods such as independent component analysis (ICA) have been useful to address this limitation, the fully data-driven nature can make it challenging to compare results across studies. Here, we introduce the NeuroMark PET approach, utilizing spatially constrained independent component analysis to define overlapping regions that may reflect the brains molecular architecture. We first generate an ICA template for the PET radiotracer florbetapir (FBP), targeting amyloid-{beta} (A{beta}) accumulation in the brain, using blind ICA on large datasets to identify replicable independent components. Only components that targeted A{beta} were included in this study, defined as A{beta} networks (A{beta}Ns), by omitting components targeting myelin or other non-A{beta} targets. Next, we use the A{beta}Ns as priors for spatially constrained ICA, resulting in a fully automated ICA pipeline called NeuroMark PET. This NeuroMark pipeline, including its A{beta}Ns, was validated against a standard neuroanatomical PET atlas, using data from the Alzheimers Disease Neuroimaging Initiative (ADNI). The study included 296 cognitively normal participants with FBP PET scans and 173 with florbetaben (FBB) PET scans, an analogue radiotracer also targeting A{beta} accumulation. Our results show that NeuroMark PET captures biologically meaningful, participant-specific features, such as subject specific loading values, consistent across individuals, and also shows higher sensitivity and power for detecting age-related changes compared to traditional atlas-based ROIs. Using this framework, we also highlight some of the advantages of using ICA analysis for PET data. In this study, an A{beta}N consists of weighted voxels and forms a pattern throughout the entire brain. For example, components may have weighted values at every voxel and can overlap with one another, enabling the separation of artifacts which may coincide with the A{beta}Ns of interest. In addition, this approach allows for the differentiation, separating white matter components, which may overlap in complex ways with the A{beta}Ns, mainly residing in the neighboring gray matter. Results also showed that the most age associated A{beta}N (representing the cognitive control network, CC1) exhibited a stronger association with age compared with macro-anatomical regions of interest. This may suggest that each NeuroMark FBP A{beta}N represents a spatial network following chemo-architectural uptake with greater biological relevance compared with anatomical ROIs. In summary, the proposed NeuroMark PET approach offers a fully automated framework, providing accurate and reproducible brain A{beta}Ns. This approach enhances our ability to investigate the molecular underpinnings of brain function and pathology, offering an alternative to traditional ROI-based analyses.

neuroscience↗

Leveraging longitudinal diffusion MRI data to quantify differences in white matter microstructural decline in normal and abnormal aging

AbstractO_ST_ABSINTRODUCTIONC_ST_ABSIt is unclear how rates of white matter microstructural decline differ between normal aging and abnormal aging. METHODSDiffusion MRI data from several well-established longitudinal cohorts of aging [Alzheimers Neuroimaging Initiative (ADNI), Baltimore Longitudinal Study of Aging (BLSA), Vanderbilt Memory & Aging Project (VMAP)] was free-water corrected and harmonized. This dataset included 1,723 participants (age at baseline: 72.8{+/-}8.87 years, 49.5% male) and 4,605 imaging sessions (follow-up time: 2.97{+/-}2.09 years, follow-up range: 1-13 years, mean number of visits: 4.42{+/-}1.98). Differences in white matter microstructural decline in normal and abnormal agers was assessed. RESULTSWhile we found global decline in white matter in normal/abnormal aging, we found that several white matter tracts (e.g., cingulum bundle) were vulnerable to abnormal aging. CONCLUSIONSThere is a prevalent role of white matter microstructural decline in aging, and future large-scale studies in this area may further refine our understanding of the underlying neurodegenerative processes. HIGHLIGHTSO_LILongitudinal data was free-water corrected and harmonized C_LIO_LIGlobal effects of white matter decline were seen in normal and abnormal aging C_LIO_LIThe free-water metric was most vulnerable to abnormal aging C_LIO_LICingulum free-water was the most vulnerable to abnormal aging C_LI

neuroscience↗

Genetic, clinical underpinnings of subtle early brain change along Alzheimer's dimensions

Alzheimers disease (AD) is associated with heterogeneous atrophy patterns. We employed a semi-supervised clustering technique known as Surreal-GAN, through which we identified two dominant dimensions of brain atrophy in symptomatic mild cognitive impairment (MCI) and AD patients: the "diffuse-AD" (R1) dimension shows widespread brain atrophy, and the "MTL-AD" (R2) dimension displays focal medial temporal lobe (MTL) atrophy. Critically, only R2 was associated with widely known sporadic AD genetic risk factors (e.g., APOE {varepsilon}4) in MCI and AD patients at baseline. We then independently detected the presence of the two dimensions in the early stages by deploying the trained model in the general population and two cognitively unimpaired cohorts of asymptomatic participants. In the general population, genome-wide association studies found 77 genes unrelated to APOE differentially associated with R1 and R2. Functional analyses revealed that these genes were overrepresented in differentially expressed gene sets in organs beyond the brain (R1 and R2), including the heart (R1) and the pituitary gland, muscle, and kidney (R2). These genes were enriched in biological pathways implicated in dendritic cells (R2), macrophage functions (R1), and cancer (R1 and R2). Several of them were "druggable genes" for cancer (R1), inflammation (R1), cardiovascular diseases (R1), and diseases of the nervous system (R2). The longitudinal progression showed that APOE {varepsilon}4, amyloid, and tau were associated with R2 at early asymptomatic stages, but this longitudinal association occurs only at late symptomatic stages in R1. Our findings deepen our understanding of the multifaceted pathogenesis of AD beyond the brain. In early asymptomatic stages, the two dimensions are associated with diverse pathological mechanisms, including cardiovascular diseases, inflammation, and hormonal dysfunction - driven by genes different from APOE - which may collectively contribute to the early pathogenesis of AD.

bioengineering↗

Tau pathology in cognitively normal older adults: Associations with brain atrophy and cognitive decline

INTRODUCTIONTau pathology, a hallmark of Alzheimers disease, is observed in the brains of virtually all individuals over 70.\n\nMETHODSUsing 18F-AV-1451 (18F-flortaucipir) PET, we evaluated tau pathology in 54 cognitively normal participants (mean age 77.5, SD 8.9) from the Baltimore Longitudinal Study of Aging. We assessed associations between PET signal and age, sex, race, and amyloid positivity. We investigated relationships between regional signal and retrospective rates of change in regional volumes and cognitive function adjusting for age, sex, and amyloid status.\n\nRESULTSGreater age, male sex, black race, and amyloid positivity were associated with higher 18F-AV-1451 retention in distinct brain regions. Retention in the entorhinal cortex was associated with lower entorhinal volume ({beta} = -1.124, SE = 0.485, p = 0.025) and a steeper decline in memory performance ({beta} = -0.086, SE = 0.039, p = 0.029).\n\nDISCUSSIONAssessment of medial temporal tau pathology will provide insights into early structural brain changes associated with later cognitive impairment and Alzheimers disease.

neuroscience↗

Predicting time to dementia using a quantitative template of disease progression

IntroductionCharacterization of longitudinal trajectories of biomarkers implicated in sporadic Alzheimers disease (AD) in decades prior to clinical diagnosis is important for disease prevention and monitoring.\n\nMethodsWe used a multivariate Bayesian model to temporally align 1369 AD Neuroimaging Initiative participants based on the similarity of their longitudinal biomarker measures and estimated a quantitative template of the temporal evolution cerebrospinal fluid (CSF) A{beta}1-42, p-tau181p, and t-tau, hippocampal volume, brain glucose metabolism, and cognitive measurements. We computed biomarker trajectories as a function of time to AD dementia, and predicted AD dementia onset age in a disjoint sample.\n\nResultsQuantitative template showed early changes in verbal memory, CSF A{beta}1-42 and p-tau181p, and hippocampal volume. Mean error in predicted AD dementia onset age was < 1.5 years.\n\nDiscussionOur method provides a quantitative approach for characterizing the natural history of AD starting at preclinical stages despite the lack of individual-level longitudinal data spanning the entire disease timeline.

neuroscience↗

Temporal order of Alzheimer’s disease-related cognitive marker changes in BLSA and WRAP longitudinal studies

Investigation of the temporal trajectories of currently used neuropsychological tests is critical to identifying earliest changing measures on the path to dementia due to Alzheimers disease (AD). We used the Progression Score (PS) method to characterize the temporal trajectories of measures of verbal memory, executive function, attention, processing speed, language, and mental state using data spanning normal cognition, mild cognitive impairment (MCI), and AD from 1661 participants with a total of 7839 visits (age at last visit 77.6 SD 9.2) in the Baltimore Longitudinal Study of Aging and 1542 participants with a total of 4467 visits (age at last visit 59.9 SD 7.3) in the Wisconsin Registry for Alzheimers Prevention. This method aligns individuals in time based on the similarity of their longitudinal measurements to reveal temporal trajectories. As a validation of our methodology, we explored the associations between the individualized cognitive progression scores (Cog-PS) computed by our method and clinical diagnosis. Digit span tests were the first to show declines in both data sets, and were detected mainly among cognitively normal individuals. These were followed by tests of verbal memory, which were in turn followed by Trail Making Tests, Boston Naming Test, and Mini-Mental State Examination. Differences in Cog-PS across the clinical diagnosis groups were statistically significant, highlighting the potential use of Cog-PS as individualized indicators of disease progression. Identifying cognitive measures that are changing in preclinical AD can lead to the development of novel cognitive tests that are finely tuned to detecting earliest changes.\n\nABBREVIATIONS

neuroscience↗